Dr. Lal PathLabs Launches Advanced Amyloidosis Test
Mumbai: Dr. Lal PathLabs has introduced a breakthrough test for accurately identifying different types of Amyloid proteins, becoming the first diagnostic chain in South Asia to offer this highly specialized test.
The test, Amyloid Typing by Laser Capture Microdissection & Mass Spectrometry, enables precise knowledge about the type of Amyloid protein, helping doctors choose the correct treatment or management plan for patients.
Samples can be collected from anywhere in India and sent to the National Reference Lab in Rohini, New Delhi for testing, making it accessible to hospitals and patients across the country.
“Our mission is to bring world-class diagnostics to India,” said Shankha Banerjee, CEO of Dr. Lal PathLabs. “We aim to provide doctors with critical insights for accurate diagnosis and personalized treatment.”
Accurate typing of Amyloid proteins is essential for guiding treatment decisions, and this advanced test allows for precise identification of amyloid subtypes, enabling targeted care.
